Correlation Between Enanta Pharmaceuticals and Viatris
Can any of the company-specific risk be diversified away by investing in both Enanta Pharmaceuticals and Viatris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enanta Pharmaceuticals and Viatris into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enanta Pharmaceuticals and Viatris, you can compare the effects of market volatilities on Enanta Pharmaceuticals and Viatris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enanta Pharmaceuticals with a short position of Viatris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enanta Pharmaceuticals and Viatris.
Diversification Opportunities for Enanta Pharmaceuticals and Viatris
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Enanta and Viatris is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Enanta Pharmaceuticals and Viatris in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viatris and Enanta Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enanta Pharmaceuticals are associated (or correlated) with Viatris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viatris has no effect on the direction of Enanta Pharmaceuticals i.e., Enanta Pharmaceuticals and Viatris go up and down completely randomly.
Pair Corralation between Enanta Pharmaceuticals and Viatris
Given the investment horizon of 90 days Enanta Pharmaceuticals is expected to under-perform the Viatris. But the stock apears to be less risky and, when comparing its historical volatility, Enanta Pharmaceuticals is 1.32 times less risky than Viatris. The stock trades about -0.5 of its potential returns per unit of risk. The Viatris is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest 1,145 in Viatris on September 3, 2024 and sell it today you would earn a total of 164.00 from holding Viatris or generate 14.32% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enanta Pharmaceuticals vs. Viatris
Performance |
| Timeline |
| Enanta Pharmaceuticals |
| Viatris |
Enanta Pharmaceuticals and Viatris Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enanta Pharmaceuticals and Viatris
The main advantage of trading using opposite Enanta Pharmaceuticals and Viatris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enanta Pharmaceuticals position performs unexpectedly, Viatris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viatris will offset losses from the drop in Viatris' long position.| Enanta Pharmaceuticals vs. Monte Rosa Therapeutics | Enanta Pharmaceuticals vs. Design Therapeutics | Enanta Pharmaceuticals vs. Werewolf Therapeutics | Enanta Pharmaceuticals vs. Ikena Oncology |
| Viatris vs. Catalent | Viatris vs. Bausch Health Companies | Viatris vs. Tilray Inc | Viatris vs. Takeda Pharmaceutical Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |